HomeComparePOLBF vs RYLD

POLBF vs RYLD: Dividend Comparison 2026

POLBF yields 3344.48% · RYLD yields 4.00%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 POLBF wins by $1284463355857.08M in total portfolio value
10 years
POLBF
POLBF
● Live price
3344.48%
Share price
$0.06
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1284463355857.10M
Annual income
$1,213,110,815,498,324,000.00
Full POLBF calculator →
RYLD
RYLD
● Live price
4.00%
Share price
$50.00
Annual div
$2.00
5Y div CAGR
5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.0K
Annual income
$899.19
Full RYLD calculator →

Portfolio growth — POLBF vs RYLD

📍 POLBF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPOLBFRYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, POLBF + RYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
POLBF pays
RYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

POLBF
Annual income on $10K today (after 15% tax)
$284,280.94/yr
After 10yr DRIP, annual income (after tax)
$1,031,144,193,173,575,300.00/yr
RYLD
Annual income on $10K today (after 15% tax)
$340.00/yr
After 10yr DRIP, annual income (after tax)
$764.31/yr
At 15% tax rate, POLBF beats the other by $1,031,144,193,173,574,500.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of POLBF + RYLD for your $10,000?

POLBF: 50%RYLD: 50%
100% RYLD50/50100% POLBF
Portfolio after 10yr
$642231677928.57M
Annual income
$606,555,407,749,162,500.00/yr
Blended yield
94.44%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

POLBF buys
0
RYLD buys
0
No recent congressional trades found for POLBF or RYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPOLBFRYLD
Forward yield3344.48%4.00%
Annual dividend / share$2.00$2.00
Payout ratio50%50%
1-year div growth0%5%
5-year div CAGR0%5%
Portfolio after 10y$1284463355857.10M$28.0K
Annual income after 10y$1,213,110,815,498,324,000.00$899.19
Total dividends collected$1279557275592.29M$6.4K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: POLBF vs RYLD ($10,000, DRIP)

YearPOLBF PortfolioPOLBF Income/yrRYLD PortfolioRYLD Income/yrGap
1← crossover$345,148$334,448.16$11,120$420.00+$334.0KPOLBF
2$11,157,548$10,788,239.94$12,357$458.31+$11.15MPOLBF
3$337,872,856$325,934,279.31$13,721$499.76+$337.86MPOLBF
4$9,585,767,941$9,224,243,985.35$15,227$544.58+$9585.75MPOLBF
5$254,836,586,625$244,579,814,927.95$16,885$593.02+$254836.57MPOLBF
6$6,349,429,806,239$6,076,754,658,549.98$18,713$645.34+$6349429.79MPOLBF
7$148,295,333,941,378$141,501,444,048,701.88$20,724$701.81+$148295333.92MPOLBF
8$3,247,334,232,557,481$3,088,658,225,240,206.50$22,938$762.73+$3247334232.53MPOLBF
9$66,684,617,157,738,690$63,209,969,528,902,180.00$25,372$828.41+$66684617157.71MPOLBF
10$1,284,463,355,857,104,100$1,213,110,815,498,324,000.00$28,047$899.19+$1284463355857.08MPOLBF

POLBF vs RYLD: Complete Analysis 2026

POLBFStock

Poolbeg Pharma plc operates as a clinical stage infectious disease pharmaceutical company in the United Kingdom. It develops POLB 001, a p38 MAP Kinase inhibitor for the treatment of severe influenza; POLB 002, an in­licensed first­in­class intranasally administered RNA­based immunotherapy for respiratory virus infections; and POLB 003, an intramuscular vaccine to prevent Melioidosis. The company also has a licensed access to micro­ and nanoencapsulation technology to develop an oral vaccine delivery platform that delivers immune stimulating antigens to various areas of the gut; and artificial intelligence powered drug program. In addition, it is involved in the development of biomarker platform to identify those at risk of developing severe disease; and vaccine discovery platform, a model-derived discovery platform to identify new vaccine candidates. Poolbeg Pharma plc was incorporated in 2021 and is headquartered in London, the United Kingdom.

Full POLBF Calculator →

RYLDETF

RYLD is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in RYLD shares.

Full RYLD Calculator →
📬

Get this POLBF vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

POLBF vs SCHDPOLBF vs JEPIPOLBF vs OPOLBF vs KOPOLBF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.